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Background: The gastrointestinal tissue plays an important role in the pathogenesis of HIV/SIV infection and serves
as a viral reservoir in infected individuals under antiretroviral therapy (ART). However, the effect of ART
administration in the very early stage of infection on HIV/SIV replication and pathogenesis in gastrointestinal tissue
has not been fully studied. In this current study, rhesus monkeys infected with SIV were treated with ART starting
at day 7 post-infection. The effect of early ART on SIV replication and infection-related pathogenic changes in
mucosal tissues of the infected monkeys was examined.
Methods: Nuclear acids were extracted from snap frozen ileum and colon tissues and mesentery lymph nodes
from SIV infected monkeys with or without ART. SIV RNA and DNA loads as well as levels of CD3, CD4 and cytokine
mRNA were measured by PCR and RT PCR from the isolated nuclear acids. Tissue sections were stained by
immuno-fluorescence labeled antibodies for CD3 and CD4.
Results: Without ART treatment, these monkeys underwent a mild SIV infection with low viral loads and slightly
decreased CD4+ T cell counts in peripheral blood. In ART treated monkeys, SIV RNA loads were undetectable in
blood with normal CD4+ T cell counts, however, SIV RNA and DNA were detected in the intestinal tissues and
mesentery lymph nodes although the levels were lower than those in untreated monkeys. The levels of CD3 and
CD4 positive cells in the tissues were similar between the infected untreated monkeys and infected ART treated
monkeys based on RT-PCR and immune-fluorescence staining of the tissue sections. Furthermore, compatible levels
of IL-6, TNF-a, IL-1b and MyD88 mRNAs were detected in most of intestinal tissues and mesentery lymph nodes of
infected ART treated and infected untreated monkeys.
Conclusions: These results suggest that early ART administration could not effectively inhibit SIV replication in
intestinal tissues and mesentery lymph nodes and could not reduce the immune activation induced by SIV
infection in the intestinal tissues.
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The gastrointestinal (GI) tract harbors a majority of
lymphocytes both in human and non-human primates.
Approximate 40-60% of T lymphocytes in the GI tract
are CCR5+ CD4+ T cells, the main target cells for
HIV/SIV infection and replication [1-4]. The gut asso-
ciated lymphoid tissue (GALT) plays an important role in
the pathogenesis of HIV infection and AIDS develop-
ment. During the early and chronic phases of HIV/SIV
infection, HIV/SIV preferentially replicates in the GALT,
leading to CD4+ T cell depletion, especially Th17 CD4+
T cells, local immune activation and mucosal barrier
dysfunction [5,6]. The pathogenic changes in GI tissue
result in microbial and microbial-product translocation
and systemic immune activation, which propels disease
progression. In long-term non-progressors (LTNP) and
antiretroviral therapy (ART) treated patients, the GALT
serves as a viral reservoir which poses a great obstacle in
virus eradication from HIV infected individuals [1,7,8].
In the early stage of HIV/SIV infection, regardless of the
route of infection, the virus infects gastrointestinal tissues
and quickly establishes a viral reservoir. When HIV infec-
ted patients are treated with ART, viral loads in peripheral
blood decline quickly to an undetectable level. However,
viral DNA and RNA can still be detected in lymphoid and
gastrointestinal tissues, indicating that virus actively repli-
cates in these tissues in spite of the ART treatment [9,10].
However, in most of these studies, infected patients were
treated with ART in their chronic phase of infection.
It is still unclear why ART is unable to effectively con-
trol and eradicate HIV from the gastrointestinal tissues.
It is speculated that ART administration at a very early
stage of infection could more effectively control HIV rep-
lication in GI compartments in which HIV is just estab-
lishing productive infection. Unfortunately, limited studies
have been reported about the effect of early ART treat-
ment on HIV infection and pathogenesis in GI tissues.
This information is very important for clinicians to design
an effective therapeutic strategy. Macaques infected with
SIV provide good animal models for studying HIV with
different treatment strategies since it is possible to examine
host and viral responses to early ART treatment in differ-
ent tissue compartments at different times post infection.
In this study, GI tissues from SIV infected rhesus
monkeys with or without ART administration at very
early phase of infection were studied to explore the
effectiveness of early ART administration on viral loads
and other pathogenic changes in gastrointestinal tissues.
Results
SIV RNA/DNA loads in blood and GI tissues from infected
monkeys with or without ART
Ten rhesus macaques were infected by intravenous
inoculation with 100 TCID50 of the pathogenic isolateSIVm251. Starting at day 7 post infection, five monkeys
were treated with ART--two reverse transcriptase inhibi-
tors (PMPA and FTC, see Materials and methods section
for details) and five monkeys were untreated as controls.
All monkeys were sacrificed on day 35 post infection
(Figure 1). Plasma viral loads and CD4+ T cell counts of
all the experimental monkeys around sacrificing time are
listed in Table 1. The SIV RNA loads in the blood of SIV
infected monkeys without ART range from 4.2 × 103 to
5.2 × 104/ml, which indicates these monkeys had a mild
SIV infection based on previous reports [11,12]. The mild
infection was also evidenced by the moderate CD4+ T
cell decline in peripheral blood (average CD4+ T cells
441/mm3). No viral RNA was detected in blood of the
infected monkeys with ART, indicating ART effectively
inhibited SIV replication. Since gastrointestinal tissues
have been implicated to be the major viral reservoir, we
evaluated the effect of early ART intervention on viral
loads of gastrointestinal tissue in the SIV infected mon-
keys with or without ART. The SIV RNA and DNA loads
in two intestinal locations (ileum and colon) and mesen-
tery lymph nodes (mln) were measured after 35 days of
SIV inoculation. As expected, both SIV RNA and DNA
were detected in mln, ileums and colons from infected,
ART naïve monkeys with detectable plasma viral RNA
loads. However, in the five SIV infected monkeys with
ART, both SIV DNA and RNA were also detected in mln,
ileums and colons despite the undetectable plasma viral
loads (Figure 2A and B). Although SIV RNA/DNA was
not always detectable in every gut tissues measured, all
ART monkeys were found to harbor SIV DNA/RNA in
the gastrointestinal tissues. Compared to those of
infected monkeys under therapy, the SIV RNA loads in
all tissues of ART naïve monkeys were higher, however,
only the viral RNA loads in colons of ART naïve mon-
keys were statistically significantly higher than those in
ART monkeys (Figure 2A). SIV DNA loads in all the
tissues of ART naïve monkeys are statistically signifi-
cantly higher than those in ART treated monkeys
(Figure 2B). Interestingly, more SIV DNA was detected
than viral RNA in the intestinal tissues from ART
monkeys, whereas, approximately equal amounts of
viral RNA and DNA were detected from ART naïve
monkey tissues (Figure 2C). These results indicate that
ART administered on day 7 post infection could not
block SIV from establishing the viral reservoir in mln
and intestinal tissues. The results also suggested that
the antiretroviral drugs might penetrate into and par-
tially block SIV replication in the tissues. However, the
drug concentrations in the intestinal tissues might not
be high enough to totally block SIV replication and
local immune cells might not remove the infected cells
in the intestinal tissues as suggested in a recent review
by Dr. Cohen [13].
Figure 1 Experimental Schedule of SIV infection and ART Administration.
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tissues with or without ART
Monitoring CD4 positive cell quantity in the tissues is
the most frequently used method for evaluating local
HIV/SIV induced pathogenic changes. Since only snap-
frozen tissues from these monkeys were available to us,
it was very difficult to isolate the immune cells from
the tissues and phenotype them by flow cytometry.
Therefore as an alternative approach we measured the
levels of CD4 and CD3 mRNA in the mln and intestinal
tissues by real time RT PCR, which served as a surro-
gate measurement for expression of CD4 and CD3 in
cells of the tested tissues. The results presented in
Figure 3 showed that the levels of CD4 and CD3 mRNA
in the intestinal tissues from infected, ART treated
monkeys were similar to those of the intestinal tissues
from infected, ART naïve monkeys. In addition, the quan-
titation of CD3 and CD4 positive cells in the intestinal tis-
sues were further assessed by immuno-fluorescent
staining in the tissue sections from two infected ART
treated monkeys (M129-08 and M132-08) and two
infected ART naïve monkeys (M139-08 and M140-08).
The representative results from monkey M129-08 and
M139-08 were included in Figures 4 and 5. No significantTable 1 Infection status and Clinical findings in Rhesus Macaq
Monkey ID Infection stage
and treatment
Inoculation
strain of SIV
M126-08 Acute +ART SIVmac251
M127-08 Acute +ART SIVmac251
M129-08 Acute +ART SIVmac251
M132-08 Acute +ART SIVmac251
M134-08 Acute +ART SIVmac251
M128-08 Acute SIVmac251
M130-08 Acute SIVmac251
M133-08 Acute SIVmac251
M139-08 Acute SIVmac251
M140-08 Acute SIVmac251differences in the numbers of CD3 and CD4 positive cells
in the tissue sections were observed between SIV infected,
ART treated monkeys and ART naïve monkeys. These
results are not unexpected since early administration of
ART did not effectively inhibit viral replication in intes-
tinal tissues.
Cytokine profiles in SIV infected intestinal tissues with/
without ART
Inflammatory responses induced by SIV replication in
gastrointestinal tissues lead to recruitment and activa-
tion of immune cells into the local area enhancing
viral replication and tissue damage. To evaluate the ef-
fectiveness of early administration of ART on patho-
genic changes in the infected intestinal tissues, mRNA
of the pro-inflammatory cytokines, IL-6, IL-1β, and
TNFα were measured by real time RT PCR in the
RNA isolated from the intestinal tissues and mln. Sig-
nificantly higher IL-6 mRNA levels were detected in
the colons from infected ART naïve monkeys com-
pared to those from infected ATR treated monkeys
(Figure 6A). No statistical differences in the levels of
TNFα and IL-1β mRNA were observed in intestinal
tissues from infected ART treated monkeys comparedues
Route of
Infection
Plasma viral loads
(copies/ml)
CD4 T
cells/mm3
IV <200 749
IV <200 829
IV <200 679
IV <200 1682
IV <200 332
IV 7343 273
IV 52361 422
IV 4200 714
IV 6716 427
IV 21974 367
Figure 2 SIV RNA (A) and DNA (B) loads in ileums, colons and mesentery lymph nodes from SIV infected ART monkeys and SIV
infected untreated monkeys. Nuclear acids were extracted from the tissues and amplified by real time PCR and RT-PCR with SIV specific primers
and probe. (C) Comparison of viral RNA and DNA levels detected in the same tissue.
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MyD88, an adapter protein used by TLRs to activate
the NF-KB transcription, is one of the important com-
ponents of innate immune responses. Therefore, the
mRNA levels of MyD88 were also monitored in intes-
tinal tissues and mln in monkeys with and without
ART. No statistically significant differences in the
mRNA levels of MyD88 were detected in the intestinal
tissues and mln in ART treated vs ART naïve monkeys
(Figure 6D). These results suggest that early ART ad-
ministration did not efficiently influence GI inflamma-
tory responses.Figure 3 Levels of CD3 mRNA (A) and CD4 mRNA (B) detected in ileu
monkeys and infected untreated monkeys. Nucleic acid were extracted
specific primers and probes.Discussion
In HIV/SIV infection, pathogenic changes in the GI tract
have been implicated as one of the main causes of dis-
ease progression and AIDS development. ART treatment
of chronically infected patients decreases plasma viral
loads to undetectable levels and maintains those levels
for many years. However, in such treated patients, HIV
remains replication active in gastrointestinal tissues and
lymphoid nodes, and as a result it is very difficult to
eradicate HIV from infected individuals. It has been
speculated that the concentration of ART in gastrointes-
tinal tissue is much lower than that in blood because thems, colons and mesentery lymph nodes from SIV infected ART
from the tissues and amplified by RT real time PCR with CD3 and CD4
Figure 4 Distribution of CD4 positive cells in ileums (A) and colons (B) from the SIV infected ART monkey M129-08 and one SIV
infected unteared monkey M139-08. Tissue sections were prepared from snap-frozen tissues and CD4 positive cells were detected by
immunufluorescent staining with anti-CD4 antibody followed by confocal miroscopy.
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to poor drug penetration. Such low levels of ART in tis-
sues could not effectively suppress HIV replication in the
tissues, making the gastrointestinal tissue a viral reservoir
[13]. Recent studies show that ART treatment of HIV-1
infected persons has a very dramatic impact on reducing
HIV-1 transmission rates to their partners [14]. Studies
in the macaque models have also demonstrated that
early drug treatment delayed or reduced the peak of
acute viremia, enhanced antiviral immune responses, and
delayed disease progression [15]. Therefore, ART has
been suggested to be administered at the early stage of
HIV infection to inhibit HIV replication and transmis-
sion and prevent pathogenic change in gastrointestinal
tract [16,17]. However, due to the hard-to-reach anatom-
ical location, few studies have been performed to monitor
the effectiveness of early ART administration on blocking
HIV replication and associated pathogenic changes in
the gastrointestinal tract, a key area for eradicating HIV
infection.
In this current study, five SIV infected monkeys were
treated with ART from day 7 post infection to day 35 of
infection. Our results showed that SIV replicated in intes-
tinal tissues and mln in spite of the early ARTadministration. Furthermore, SIV invaded intestinal tis-
sues and established viral reservoirs rapidly and adminis-
tration of antiviral drugs as early as day 7 post infection
could neither efficiently suppress viral replication, nor
eliminate the infected cells from this established reservoir.
SIV infection in gastrointestinal lymphoid tissues leads to
rapid depletion of CD4+ cells in the tissues. In the current
study, comparable CD4 and CD3 positive cells in the in-
testinal tissues measured by immuno-fluorescence staining
and their mRNA levels in the ART treated and untreated
monkeys suggested that early ART administration failed to
prevent CD4+ cell depletion in gastrointestinal tissues.
However, it is also possible that all infected monkeys in this
experiment underwent a moderate SIV infection and might
experience a slight decline of CD4+ cells in intestinal tis-
sues regardless of ART administration. Therefore, it is not
expected to observe a significant CD4+ T cell depletion in
the gut tissues with such a mild and short duration of SIV
infection in these experimental monkeys (Dr. Apetrei,
University of Pittsburgh, personal communications).
HIV/SIV replication in gastrointestinal tissues induces
immune activation and upregulation of multiple cyto-
kines and chemokines, which stimulate inflammatory
response and cell death [18-20]. ART administration
Figure 5 Distribution of CD3 positive cells in ileums (A) and colons (B) from the SIV infected ART monkey M129-08 and one SIV
infected unteared monkey M139-08. Tissue sections were prepared from snap-frozen tissues and CD3 positive cells were detected by
immunufluorescent staining with anti-CD3 antibody followed by confocal miroscopy.
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sues of HIV infected patients and SIV infected monkeys
[21,22]. One important aspect of immune activation is
T cell activation with upregulation of MHC class II and
CD38 on cell membranes. Since only snap-frozen intes-
tinal tissues from the experimental monkeys were avail-
able for this study, immune cells in the tissue were not
able to be evaluated by flow cytometry for immune acti-
vation status. However, mRNA levels of inflammatory
cytokines were measured in the tissues. Except IL-6
mRNA levels in the colons, there were no differences
in mRNA levels of cytokines and MyD88 in intestinal
tissues and mln from ART treated monkeys versus ART
naïve monkeys. The possibilities for the observed dis-
crepancies are: 1) Severe immune activation might not
occur in the tested tissues due to the mild infection;
2) ART could not prevent SIV induced cytokine pro-
duction; 3) there might be a combination of 1) and 2).
Due to the tissue availability, the cytokine and chemokine
levels in the tissues were only measured at mRNA level
in this study. In a subsequent study, we will measure thecytokine and chemokine levels at protein level in the
tissues as well.
HIV/SIV infection with different levels of viral loads
and different rates of CD4+ T cell decline is observed in
an infected population. Most studies have focused on the
severe cases of HIV/SIV infection. In this study, we
reported mild cases of SIV infection and provided a
snapshot of the SIV induced pathogenic changes in intes-
tinal tissues with and without early ART administration,
which is less studied, but very important since many
people have contracted mild HIV infection with low viral
loads and slow CD4+ T cell decline.
There are certain limitations in this study by using the
frozen tissues from the experimental monkeys: such as,
the immune cells could not be isolated from the frozen
tissues for precise numeration of CD4 and CD8 T cells
in the tissues by flow cytometer analysis, or numeration
of SIV infected CD4 T cells, or accurately measuring
SIV RNA/DNA copies/number of CD4 T cells. Hence,
future studies with fresh intestinal tissues are warranted.
Furthermore, due to the limitation of available monkeys,
Figure 6 Levels of IL-6 mRNA (A),TNF-a mRNA (B), IL-1b (C) and MyD88 mRNA (D) detected in ileums, colons and mesentery lymph
nodes from SIV infected ART monkeys and infected untreated monkeys. Nucleic acids were extracted from the tissues and amplified by RT
real-time PCR with IL-6, TNF-a, IL-1b and MyD88 specific primers and probes.
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Future studies that characterize transcriptional profiles
of infected with or without ART and uninfected intestinal
tissues will be important to the identification of molecu-
lar mechanism of pathogenesis and potential targets for
therapeutic intervention.
Conclusions
In this study, the effect of early ART treatment on SIV
replication and pathogenic changes in intestinal tissues
was evaluated in mild SIV infected monkeys. The results
suggest that early ART administration could not effect-
ively inhibit SIV replication in intestinal tissues and mes-
entery lymph nodes and could not reduce the immune
activation induced by SIV infection in the intestinal
tissues.
Materials and methods
Monkeys, virus infection and sample collection
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use ofLaboratory Animals of the National Institutes of Health.
The protocol was approved by the Institutional Animal
Care and Use Committee at the University of Pittsburgh
(Assurance Number A3187-01). Surgeries were performed
under anesthesia induced and maintained with keztamine
hydrochloride and medetomidine hydrochloride, and all
efforts were made to minimize suffering.
The ten Indian-origin rhesus macaques were infected by
intravenous inoculation with 100 TCID50 of the patho-
genic isolate SIVm251 that had been grown in CEMx174
cells. At day 7 post infection, five monkeys were treated
with the Antiretroviral drugs (ART) and five monkeys
were untreated as controls. The ART consisted of two
reverse transcriptase inhibitors, 9-[2-(phosphonyl-methoxy)
propyl] adenine (PMPA) and 29-deoxy-5-fluoro-39-thia-
cytidine (FTC). PMPA was administered at 30mg/kg
daily from day 7 to day 20 post infection and 20mg/kg
daily from day 21 to day 35 by subcutaneous injection;
FTC was administered at 30mg/kg daily from day 7 to
day 35 post infection via subcutaneous injection. All
monkeys were sacrificed on day 35 post infection. CD4+
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blood two days before and on the sacrificing day respect-
ively (Figure 1). Mesentery lymph nodes, ileum and colon
tissues from these monkeys were snap frozen immedi-
ately after sacrifice and used in this current study.
Nucleic acid isolation and RT real time PCR
Two hundred milligrams of each GI tissue was homogenized
using the hard tissue disposable probes and TH-01
Homogenizer (OMNI International). The RNA and DNA
were isolated simultaneously from the same homogenized
tissue mixture using the AllPrep DNA/RNA mini W kit (Qia-
gen) according to the manufacturer’s protocol. Twenty nano-
grams of DNA were used for measuring SIV DNA loads in
the tissues. Two hundred nanograms of RNA from the tis-
sues were reversely transcribed with random hexamers by
SuperScript II Reverse Transcriptase (Invitrogen) following
the protocol provided by the manufacturer. Twenty nano-
grams of cDNA equivalent were used to quantitate SIV
RNA loads and the relative mRNA levels of CD4, CD3 and
the inflammatory cytokines by real time PCR. A 25 μl Taq-
ManW PCR was performed by mixing 20ng of the DNA or
cDNA with TaqManW Universal Mastermix (Applied Biosys-
tems), target specific and 18S primers and probes. The PCR
amplification and product detection were performed with a
ViiA 7 real time PCR machine (Applied Biosystems). The
PCR cycling program consisted of 50 two-step cycles of 15s
at 95°C and 60s at 60°C. The nucleic acid from each speci-
men was amplified in duplicate. A no-template and reverse
transcriptase negative controls were included in each PCR
run. To accurately quantify the target molecules, endogen-
ous gene 18S was co-amplified using commercially available
primers and probe (Applied Biosystems) in each run as a
multiplex assay. In the result analysis, the Ct value of a spe-
cific target was adjusted by the co-amplified 18S Ct value to
compensate the subtle differences in DNA and cDNA inputs
between samples. For quantitation of SIV loads in gastro-
intestinal tissue samples, the serial dilutions of SIV 17E virus
stock with known copy number were included in each PCR
run to generate a standard curve. SIV loads in the samples
were quantitated using the following primers and probe [23],
which targeted SIV long terminal repeat (LTR): LTR forward
primer - 5’ TGG GAG GTT CTC TCC AGC AC, LTR re-
verse primer-5’ AAT GGC AGC TTT ATT GAA GAG G
and LTR probe- 6FAM 5’ TTC CCT GCT AGA CTC TCA
CCA GCA CTT GG TAMRA. To compare the mRNA
levels detected in the tissues, a series of three or four times
ten-fold dilutions of the samples containing high mRNA
levels of CD4, CD3 or inflammatory cytokines were
included in each PCR run to generate an arbitrary stand-
ard curve for relative quantification of the CD4, CD3 or
cytokines in tissue samples. The cytokine primers and
probes used for relative quantification were purchased
from ABI: CD3—RH02826503; CD4—Rh02621720; IL-6—Rh02789322_m1; TNF-a— Rh02789783_m1; IL-1B—
Rh02789775_m1 and MyD88— Rh01573837_m1.
Immunofluorescence staining and quantitative image
analysis
The immunofluorescence staining was performed by
incubating tissue sections with either mouse anti-human
CD4 (Leica Microsystem) Abs at a 1:20 dilution or Rabbit
anti-human CD3 (Dako Cytomation) Abs at a 1:50 dilu-
tion, subsequently incubated with Cy3-conjugated sec-
ondary Abs respectively. Following nuclear staining with
Hoechst (Sigma-Aldrich), sections were mounted with
Vectashield mounting medium (Vector Laboratories).
Laser scanning confocal microscopy was performed with
an Olympus (Tokyo, Japan) FluoView 1000 laser confocal
microscope.
Statistical analysis
Student’s T-Test was used to compare the means of SIV
loads and relative mRNA quantity of inflammatory cyto-
kines in the GI tissues from monkeys with or without
ART. A two-sided alpha value of 0.05 was set for statis-
tical significance.
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